Jade Biosciences, Inc.
Support and Resistance Levels
Past performance
News About JBIO
All events for JBIO
All deals for JBIO
Financial Ratios
Financial Statements
JBIO vs Sector & Peers
About Jade Biosciences, Inc.
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts. Website jadebiosciences.com
Headquarters Waltham, MA, US